Effects progestogel for postpartum engorgement of the breast

Cover Page

Abstract


Background. Severe breast engorgement can cause substantial discomfort for mothers and interfere with an infant’s ability to feed at the breast.

Aim of the study was to clarify the possibility of the influence of percutaneous the progesterone-containing gel (progestogel) to eliminate strong postpartum engorgement of the breast in lactating women.

Materials and methods. 23 patients were examined. The progestogel for transdermal therapy in an amount of 2.5-3 g was applied to the breast. Before application and after 20 min application progestogel measured the density of the mammary glands with the help of tonometer.

Results. According to our observations, application of 2.5-3g of the progestogel on the breast skin is not leading to reduction of breast swelling, engorgement and tenderness.

Conclusions. Transdermal application progestogel does not reduce the degree of engorgement of the mammary glands in the postpartum period.


Nikolai P Alekseev

Author for correspondence.
ultra3@yandex.ru
Saint Petersburg State University
Russian Federation

Professor of Department Physiology, Faculty of biology

Nadejda E Тalalaeva

talapaeva@gmail.com
FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”
Russian Federation

Med. Dr

  • Neville MC, Morton J, Umemura S. Lactogenesis. The transition from pregnancy to lactation. Pediatr Clin North Am. 2001;48:35-52.
  • Eriksson M, Lindh B, Uvnäs-Moberg K, Hökfelt T. Distribution and origin of peptide-containing nerve fibres in the rat and human mammary gland. Neuroscience. 1996;70(1):227-45. doi: 10.1016/0306-4522(95)00291-P.
  • Mangesi L, Dowswell T. Treatments for breast engorgement during lactation. Cochrane Database Syst Rev. 2010:1-25. doi: 10.1002/14651858.cd006946.pub2.
  • Пустотина О.А., Павлютенкова Ю.А. Лактационный мастит и лактостаз // Рос. вест. акушера-гинеколога. – 2007. – № 2. – С. 55–57. [Pustotina OA, Pavlutenkova UA. Lactacionnii mastit i lactostaz. Ros vest akush gynecol. 2007;(2):55-57. (In Russ.)]
  • Пустотина О.А. Опыт лечения лактационного мастита у 642 родильниц в России. Сравнительный анализ с международными рекомендациями // Архив акушерства и гинекологии им. В.Ф. Снегирева. – 2015. – № 2. – С. 42–47. [Pustotina OA. Summing up the experience gained in the treatment of puerperal mastitis in 642 patients in Russia. Comparative analysis with international recommendations. V.F. Snegirev Archives of Obstetrics and Gynecology. 2015;(2):42-47. (In Russ.)]
  • Инструкция к применению препарата Прожестожель. [Instruktsiya k primeneniyu preparata Prozhestozhel›(In Russ.)]. http:// www.rlsnet.ru/tn_index_id_12887.htm.
  • Алексеев Н.П., Ильин В.И., Талалаева Н.Е Вклад выжимающей компоненты исполнительного механизма молоковыводящего аппарата в процессе выведения молока у лактирующих женщин // Журнал акушерства и женских болезней. – 2014. – № 4. – С. 91–97. [Alekseev NP, Ilyin VI, Talalaeva NE. The contribution pulsating pressure component of the breast pump mechanism on process milk expression from mammary gland lactating women. Journal of Obstetrics and Women’s Diseases. 2014;(4):91-97. (In Russ.)]
  • Robson BA. Breast engorgement in breastfeeding mothers: Doctoral dissertation. Case Western Reserve University. Cleveland; 1990.
  • Nappi C, Affinito P, Di Carlo C, et al. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease. Endocrinol Invest. 1992;15(11):801-806. doi: 10.1007/ BF03348808.

Views

Abstract - 38

PDF (Russian) - 34


Copyright (c) 2017 ECO-vector LLC

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.